RA Capital Management Shows New 6.1% Stake in Anthera Pharmaceuticals (ANTH)
Tweet Send to a Friend
In a 13G filing on Anthera Pharmaceuticals (NASDAQ: ANTH), Peter Kolchinsky's hedge fund RA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE